Aripiprazole Clinical Trials

• Aripiprazole Open-Label, Safety and Tolerability Study
  ClinicalTrials.gov Identifier: NCT00102518 - Active, not recruiting
  Schizophrenia; Bipolar Disorder
  
• Aripiprazole in Adolescents with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00102063 - Active, not recruiting
  Schizophrenia
  
• Assessment of Interactions between Methamphetamine and Aripiprazole - 1
  ClinicalTrials.gov Identifier: NCT00089440 - Active, not recruiting
  Amphetamine-Related Disorders
  
• A Study of Aripiprazole in Patients with Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00105196 - Active, not recruiting
  Major Depressive Disorder
  
• Aripiprazole in Children and Adolescents with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00110461 - Active, not recruiting
  Bipolar Disorder
  
• Aripiprazole Treatment of Prodromal Patients
  ClinicalTrials.gov Identifier: NCT00237874 - Active, not recruiting
  Schizophrenia; Psychosis
  
• Aripiprazole to Reduce Cocaine Relapse
  ClinicalTrials.gov Identifier: NCT00276874 - Recruiting
  Cocaine-Related Disorders
  
• Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
  ClinicalTrials.gov Identifier: NCT00239356 - Active, not recruiting
  Schizophrenia
  
• Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
  ClinicalTrials.gov Identifier: NCT00328367 - Active, not recruiting
  Schizophrenia
  
• A Multicenter, Double-Blind, Study on the Efficacy and Safety of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With a Recent Manic or Mixed Episode
  ClinicalTrials.gov Identifier: NCT00277212 - Recruiting
  Bipolar I Disorder With a Recent Manic or Mixed Episode
  
• The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00222833 - Active, not recruiting
  Overweight; Hyperlipidemia; Cardiovascular Diseases
  
• Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents
  ClinicalTrials.gov Identifier: NCT00545467 - Active, not recruiting
  DSM-IV Schizophrenia; Schizoaffective Disorder
  
• Efficacy and Safety of Aripiprazole
  ClinicalTrials.gov Identifier: NCT00216723 - Recruiting
  Schizophrenia; Bipolar Disorder
  
• Trial of Aripiprazole in the Treatment of CD in Adolescents
  ClinicalTrials.gov Identifier: NCT00250705 - Recruiting
  Conduct Disorder
  
• Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
  ClinicalTrials.gov Identifier: NCT00194077 - Recruiting
  Bipolar Disorder
  
• Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00320671 - Recruiting
  Schizophrenia
  
• Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
  ClinicalTrials.gov Identifier: NCT00198107 - Recruiting
  Autistic Disorder
  
• Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
  ClinicalTrials.gov Identifier: NCT00205660 - Recruiting
  Schizophrenia; Type 2 Diabetes Mellitus
  
• A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
  ClinicalTrials.gov Identifier: NCT00261443 - Recruiting
  Depressive Disorder, Major
  
• Aripiprazole Oral Acceptability Trial
  ClinicalTrials.gov Identifier: NCT00101569 - Completed
  Schizophrenia
  
• The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
  ClinicalTrials.gov Identifier: NCT00556140 - Active, not recruiting
  Psychotic Depression
  
• Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children
  ClinicalTrials.gov Identifier: NCT00468130 - Recruiting
  Autism
  
• Study of Three Doses of Aripiprazole in Patients with Acute Schizophrenia
  ClinicalTrials.gov Identifier: NCT00080327 - Completed
  Schizophrenia
  
• Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
  ClinicalTrials.gov Identifier: NCT00223418 - Active, not recruiting
  Schizophenia Disorder; Schizoaffective Disorder
  
• The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
  ClinicalTrials.gov Identifier: NCT00468533 - Recruiting
  Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome
  
• Aripiprazole in Children and Adolescents with Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00116259 - Recruiting
  Bipolar Disorder; Attention Deficit Hyperactivity Disorder
  
• Study of alternate formulation of aripiprazole in agitated patients with schizophrenic disorders
  ClinicalTrials.gov Identifier: NCT00036127 - Completed
  Schizophrenia
  
• Study of Aripiprazole in the Treatment of Patients with Psychosis Associated with Dementia of the Alzheimer's Type
  ClinicalTrials.gov Identifier: NCT00036114 - Completed
  Alzheimer Disease
  
• Study of Aripiprazole in the Treatment of Patients with Psychosis Associated with Dementia of the Alzheimer's Type
  ClinicalTrials.gov Identifier: NCT00041678 - Completed
  Alzheimer Disease
  
• Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00102479 - Completed
  Schizophrenia; Mania
  
• Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181779 - Active, not recruiting
  Bipolar Disorder; Mania
  
• Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-
  ClinicalTrials.gov Identifier: NCT00392197 - Recruiting
  Schizophrenia
  
• Effects of Aripiprazole on Cocaine Craving and Self-Administration
  ClinicalTrials.gov Identifier: NCT00373880 - Recruiting
  Cocaine Abuse
  
• Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
  ClinicalTrials.gov Identifier: NCT00241176 - Recruiting
  Tourette's Syndrome; Tic Disorders
  
• Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00345033 - Recruiting
  Schizophrenia; Insulin Resistance
  
• Aripiprazole in Children With Autism: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00208533 - Recruiting
  Autism
  
• The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00209027 - Recruiting
  Schizophrenia
  
• Aripiprazole in the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00226317 - Recruiting
  Bipolar Disorder
  
• Aripiprazole in Patients with Acute Mania
  ClinicalTrials.gov Identifier: NCT00095511 - Completed
  Bipolar Disorder
  
• Study of Aripiprazole in Subjects with Alcoholism
  ClinicalTrials.gov Identifier: NCT00082199 - Completed
  Alcoholism
  
• BMI and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine.
  ClinicalTrials.gov Identifier: NCT00312598 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Mood Disorders With Psychotic Features
  
• Aripiprazole Augmentation of Antidepressants in PTSD
  ClinicalTrials.gov Identifier: NCT00489866 - Recruiting
  PTSD
  
• Olanzapine versus Aripiprazole in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00103571 - Completed
  Schizophrenia
  
• Switching Medication to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044655 - Recruiting
  Schizophrenia
  
• Study of Aripiprazole in Patients with Acute Bipolar Mania
  ClinicalTrials.gov Identifier: NCT00097266 - Completed
  Bipolar Disorder
  
• An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders.
  ClinicalTrials.gov Identifier: NCT00308074 - Recruiting
  Autism; Asperger's Disorder; Pervasive Developmental Disorder
  
• Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents
  ClinicalTrials.gov Identifier: NCT00573716 - Recruiting
  SSRI Therapy Affects Bone Mineral Content
  
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
  ClinicalTrials.gov Identifier: NCT00332241 - Recruiting
  Autistic Disorder; Behavorial Problems
  
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
  ClinicalTrials.gov Identifier: NCT00337571 - Recruiting
  Behavioral Symptoms; Autistic Disorder
  
• Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00194012 - Recruiting
  Bipolar Disorder
  
• Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00395915 - Recruiting
  Schizophrenia
  
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00508157 - Recruiting
  Metabolic Syndrome; Schizophrenia
  
• An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00221416 - Recruiting
  Bipolar Disorder
  
• Study of Aripiprazole in Patients with Bipolar I Disorder with a Major Depression Episode
  ClinicalTrials.gov Identifier: NCT00080314 - Completed
  Bipolar Disorder
  
• A Study of Aripiprazole in Patients with Bipolar I Disorder with a Major Depressive Episode
  ClinicalTrials.gov Identifier: NCT00094432 - Completed
  Bipolar I Disorder
  
• Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00036101 - Completed
  Bipolar Disorder
  
• Study of Aripiprazole in the Treatment of Patients with Acute Symptoms of Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00046384 - Completed
  Bipolar I disorder
  
• Aripiprazole for the Treatment of Refractory Anxiety
  ClinicalTrials.gov Identifier: NCT00438386 - Recruiting
  Generalized Anxiety Disorder; Panic Disorder
  
• Broad Effectiveness: Study with Aripiprazole
  ClinicalTrials.gov Identifier: NCT00036361 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed with Dementia
  ClinicalTrials.gov Identifier: NCT00095719 - Completed
  Dementia; Alzheimer's Disease
  
• Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD
  ClinicalTrials.gov Identifier: NCT00305370 - Recruiting
  Bipolar Disorder; Attention Deficit Hyperactivity Disorder
  
• Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00088049 - Completed
  Schizophrenia
  
• Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM
  ClinicalTrials.gov Identifier: NCT00497055 - Not yet recruiting
  Substance Abuse; HIV Infections
  
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
  ClinicalTrials.gov Identifier: NCT00365859 - Recruiting
  Autistic Disorder; Behavioral Symptoms
  
• Study of Aripiprazole in Patients with a history of Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00036348 - Completed
  Bipolar Disorder
  
• A Long-Term Study of Aripiprazole in Patients with Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00095745 - Completed
  Major Depressive Disorder
  
• Aripiprazole in the Treatment of Tourette's Syndrome
  ClinicalTrials.gov Identifier: NCT00282139 - Recruiting
  Tourette's Syndrome
  
• A Study of Adjunctive Aripiprazole in Patients with Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00095758 - Completed
  Major Depressive Disorder
  
• A Study of Adjunctive Aripiprazole in Patients with Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00095823 - Completed
  Major Depressive Disorder
  
• Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
  ClinicalTrials.gov Identifier: NCT00541502 - Not yet recruiting
  Psychotic Disorders
  
• Aripiprazole Augmentation Therapy in Treatment-Resistant Depression
  ClinicalTrials.gov Identifier: NCT00276978 - Recruiting
  Therapy-Resistant Depression
  
• Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
  ClinicalTrials.gov Identifier: NCT00567099 - Recruiting
  Schizophrenia; Sensory Gating
  
• Aripiprazole in Patients with Psychosis Associated with Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00095810 - Completed
  Parkinson's Disease; Psychoses
  
• "Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)."
  ClinicalTrials.gov Identifier: NCT00374348 - Recruiting
  Schizophrenia; Obsessive Compulsive Disorder
  
• Aripiprazole in Fragile X Syndrome
  ClinicalTrials.gov Identifier: NCT00420459 - Recruiting
  Fragile X Syndrome; Behavioral Problems Associated With Fragile X Syndrome
  
• Effects of Aripiprazole in Overweight Patients Treated with Olanzapine for Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00095524 - Completed
  Body Weight Change; Schizophrenia; Psychotic Disorder
  
• Aripiprazole as Augmentation for TRD
  ClinicalTrials.gov Identifier: NCT00174876 - Completed
  Depression
  
• A Placebo-Controlled, Cross-Over Trial of Aripiprazole
  ClinicalTrials.gov Identifier: NCT00351936 - Completed
  Schizophrenia
  
• Effect on Cognitive Function of a Treatment With Aripiprazole
  ClinicalTrials.gov Identifier: NCT00329810 - Completed
  Schizophrenia
  
• Aripiprazole and Lexapro Drug Interaction Study
  ClinicalTrials.gov Identifier: NCT00361790 - Completed
  Healthy
  
• A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00300846 - Completed
  Schizophrenia
  
• Aripiprazole and Effexor XR Drug Interaction Study
  ClinicalTrials.gov Identifier: NCT00362271 - Completed
  Healthy
  
• A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
  ClinicalTrials.gov Identifier: NCT00237939 - Completed
  Schizophrenia
  
• Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00283179 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
  ClinicalTrials.gov Identifier: NCT00292409 - Completed
  Schizophrenia and Schizoaffective Disorder
  
• Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00167817 - Completed
  Schizophrenia
  
• Aripiprazole Effects on Alcohol Reactivity and Consumption
  ClinicalTrials.gov Identifier: NCT00183235 - Completed
  Alcohol Dependence
  
• Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00202007 - Completed
  Schizophrenia
  
• Schizophrenia Trial of Aripiprazole
  ClinicalTrials.gov Identifier: NCT00237913 - Completed
  Schizophrenia
  
• Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms
  ClinicalTrials.gov Identifier: NCT00440713 - Completed
  Posttraumatic Stress Disorder
  
• A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00363337 - Completed
  Bipolar Depression
  
• Aripiprazole in Late Life Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00194038 - Completed
  Bipolar Disorder
  
• Study of Aripiprazole in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00257972 - Completed
  Bipolar Disorder
  
• The Effects of Aripiprazole on Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00224822 - Completed
  Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Metabolic Syndrome X
  
• Drug-Drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
  ClinicalTrials.gov Identifier: NCT00321516 - Completed
  Bipolar Disorder
  
• A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
  ClinicalTrials.gov Identifier: NCT00198055 - Completed
  Asperger's Disorder; Pervasive Developmental Disorder
  
• Aripiprazole Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00198198 - Completed
  Bipolar Depression
  
• Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)
  ClinicalTrials.gov Identifier: NCT00221962 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
  ClinicalTrials.gov Identifier: NCT00177008 - Completed
  Schizophrenia; Schizoaffective Disorder; Social Anxiety Disorder
  
• Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)
  ClinicalTrials.gov Identifier: NCT00211302 - Terminated
  Schizophrenia or Schizoaffective Disorder